<sup>18</sup>F-氟脱氧葡萄糖PET在体检中的应用价值研究

杨忠毅; 管樑

¹⁸F-氟脱氧葡萄糖PET在体检中的应用价值研究

杨忠毅 , 管樑

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 5: (289-291,317)

引用本文:

Citation:

¹⁸F-氟脱氧葡萄糖PET在体检中的应用价值研究

杨忠毅,
管樑

200025 上海, 上海交通大学医学院附属瑞金医院核医学科
中图分类号: R817.4

The value of ¹⁸F-fluorodeoxyglucose PET in application of medical examination

Department of Nuclear Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China
CLC number: R817.4

摘要: ¹⁸F-氟脱氧葡萄糖(¹⁸F-FDG)PET作为一种现代化的影像技术,已经越来越受到人们的重视.在此主要从PET的发展、恶性病变与良性病变的检出、假阳性与假阴性的情况以及成本效益分析等方面综述¹⁸F-FDG PET在体检中的临床应用.
- 氟脱氧葡萄糖F18 /
- 体层摄影术,发射型计算机 /
- 体检
Abstract: More and more emphasis has been put on ¹⁸F-fluorodeoxyglucose PET, which is regarded as a modem screening tool. We reviewed the clinical application of ¹⁸F-fluorodeoxyglucose PET in medical examination as the following aspects:the development of PET imaging, the detection of malignant and benign lesions, false positive and false negative and analyzes of cost-effectiveness. A large amounts of investigations show the significance of the clinical application of ¹⁸F-fluorodeoxyglucose PET in medical examination.
- FluorodeoxyglueoseF18 /
- Tomography,emission-computed /
- Medical examination
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	American Cancer Society. Cancer facts and figures 2000. Atlanta:American Cancer Society. 2000.1-2.
[2]	Michiru Ide, Yutaka Suzuki. Is whole-body FDG-PET valuable for health screening?. Eur J Nucl Med Mol Imaging, 2005, 32(3):339-341.
[3]	Ide M. Cancer screening with FDG-PET. Q J Nucl Med Mol Imaging, 2006, 50(1):23-27.
[4]	Israel O, Yefremov N. Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal loci of ¹⁸F-FDG uptake:incidence, localization patterns, and clinical Significance. J Nucl Med, 2005, 46(5):758-762.
[5]	Yasuda S, Ide M. PET and cancer screening. Ann Nucl Med, 2005, 19(3):167-177.
[6]	Chen YK, Ding HJ, Su CT, et al. Application of PET and PET/CT imaging for cancer screening. Anticancer Res,2004, 24(6):4103-4108.
[7]	Yasuda S, lde M, Fujii H, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer, 2000, 83(12):1607-1611.
[8]	Hustinx R, Benard F, Alavi A. Whole-body PET imaging in the management of patients with cancer. Semin Nuel Med, 2002, 32(1):35-46.
[9]	Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology, 2004, 231(2):305-332.
[10]	Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res, 2005, 25(2B):1421-1426.
[11]	Fischer BM, Mortensen J. The future in diagnosis and staging of lung cancer. Respiration, 2006, 73(3):267-276.
[12]	Borrego Dorado I, Vazquez Albertino R. A proposal for the rational use of the PET in oncology. Rev Esp Med Nucl, 2002, 21(3):163-173.
[13]	Chen YK, Kao CH, Liao AC, et al. Colorectal cancer screening in asymptomatic adults. Anticancer Res, 2003, 23(5b):4357-4361.
[14]	Byrne AM, Hill AD, Skehan S J, et al. Positron emission tomography in the staging and management of breast cancer. Br J Surg, 2004, 91(11):1398-1409.
[15]	Higashi T, Saga T, Nakamoto Y, et al. Diagnosis of paucreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) usefulness and limitations in "clinical reality". Ann Nucl Med, 2003, 17(4):261-279.
[16]	Meignan M, Haioun C, hti E, et al. Value of[¹⁸F]fluorodeoxyglucosepositron emission tomography in managing patients with aggres-sive non-Hodgkin's lymphoma. Clin Lymphoma Myeloma,2006, 6(4):306-313.
[17]	Tamara L, Velez I, Tamara C. Positron emission tomography:a promising diagnostic modality for head and neck pathology. J Oral Maxillofac Surg, 2006, 64(8):1272-1277.
[18]	于长海,汪涛,孙玉鹗,等.肺部良性结节性病变¹⁸F-脱氧葡萄糖正电子发射体层摄影术检查.中华外科杂志,2006,44(2):90-92.
[19]	汪涛,初向阳,孙玉鹗,等.¹⁸F-脱氧葡萄糖正电子发射体层显像检查在肺结核患者中的应用.中国胸心血管外科临床杂志,2006,13(2):73-76.
[20]	Chang JM, Lee H J, Goo JM, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol, 2006, 7(1):57-69.
[21]	Kalvin B, Fekeshazy A, Lengyel Z, et al. Cost-effective PET investigations in oncology. Magy Onkol, 2002, 46(3):203-223.
[22]	Sloka JS, Hollett PD, Mathews, M. Cost effectiveness of positron emission tomography in canada. Med Scl Monit, 2005, 7(5):351-360.
[23]	Gugiani A, Grimaldi A, Rossetti C, Economic analyses on the use of positron emission tomograptly for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy. Q J Nucl Med Mol Imaging, 2004, 48(1):49-61.
[24]	顾爱春,黄钢.PET在肿瘤方面应用的成本效益分析.国际放射医学核医学杂志,2006,30(2):65-68.
[25]	李彪,廖日强.FDG-PET在非小细胞肺癌分期中的成本效益分析.循证医学,2005,5(3):140-142.
[26]	Weckesser M, Schober O. Is whole-body FDG-PET valuable for health screehing?. Against Eur J Nucl Mol Imaging, 2005, 32(3):342-343.

[1]	李剑明 , 李亚明 . 棕色脂肪组织与¹⁸F-氟脱氧葡萄糖PET. 国际放射医学核医学杂志, 2007, 31(4): 205-207,231.
[2]	杨吉刚 , 李春林 . ¹⁸F-氟脱氧葡萄糖PET及PET-CT在食管癌中的. 国际放射医学核医学杂志, 2007, 31(1): 31-33.
[3]	赵德善 , 乔振华 . ¹⁸F-氟脱氧葡萄糖PET-CT在淋巴瘤中的应用价值. 国际放射医学核医学杂志, 2007, 31(3): 141-144.
[4]	宋少莉 , 黄钢 . ¹⁸F-氟脱氧葡萄糖PET监测实体瘤放化疗疗效的应用进展. 国际放射医学核医学杂志, 2007, 31(5): 284-288.
[5]	邢岩 , 赵晋华 . ¹⁸F-氟脱氧葡萄糖PET及PET-CT早期诊断肿瘤复发. 国际放射医学核医学杂志, 2007, 31(6): 341-344.
[6]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[7]	郑磊 , 李前伟 . ¹⁸F-氟脱氧葡萄糖PET在原发陛肝细胞癌中的应用. 国际放射医学核医学杂志, 2008, 32(1): 23-26.
[8]	张悦 , 高硕 . ¹⁸F-氟脱氧葡萄糖PET在淋巴瘤中的应用价值. 国际放射医学核医学杂志, 2007, 31(5): 292-295.
[9]	张悦 . ¹⁸F-氟脱氧葡萄糖PET和PET-CT在结直肠癌术后复发或转移中的应用价值. 国际放射医学核医学杂志, 2007, 31(1): 34-36.
[10]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.